Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.59B |
| 2 |
TotalEnergies
TTE
|
+$1.27B |
| 3 |
Warner Bros
WBD
|
+$838M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$782M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$707M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$2.77B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.27B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.6B |
| 5 |
Microsoft
MSFT
|
+$1.58B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.21% |
| 2 | Financials | 9.57% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Healthcare | 7.31% |
| 5 | Communication Services | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORGN
6176
DELISTED
Origin Materials
ORGN
| $59.3K | ﹤0.01% |
9,330
+5,703
| +157% | +$83.3K |
|
|
ABVEW
6177
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
| $59K | ﹤0.01% |
168,645
| – | – |
|
6178
CALL
Rezolute
RZLT
$451M
| $59K | ﹤0.01% |
+25,000
| New | +$196K |
|
6179
AC Immune
ACIU
$233M
| $58.3K | ﹤0.01% |
18,555
+5,920
| +47% | +$18.7K |
|
|
AIFC
6180
AI Financial Corp
AIFC
$58.9M
| $57.9K | ﹤0.01% |
52,632
+15,731
| +43% | +$30.3K |
|
|
BTM
6181
DELISTED
Bitcoin Depot
BTM
| $57.3K | ﹤0.01% |
6,347
-23,865
| -79% | -$366K |
|
6182
Spectral AI Warrants
MDAIW
$5.69M
| $55.6K | ﹤0.01% |
123,629
| – | – |
|
|
AUTL
6183
Autolus Therapeutics
AUTL
$506M
| $55.2K | ﹤0.01% |
27,749
-466,004
| -94% | -$716K |
|
6184
CarParts.com
PRTS
$45.9M
| $55.1K | ﹤0.01% |
11,011
-598
| -5% | -$3.35K |
|
|
CXE
6185
DELISTED
MFS High Income Municipal Trust
CXE
| $54.5K | ﹤0.01% |
+14,737
| New | +$54.8K |
|
6186
Cheche Group
CCG
$35.8M
| $53.5K | ﹤0.01% |
1,842
+278
| +18% | +$9.59K |
|
6187
CALL
ASP Isotopes
ASPI
$510M
| $53.5K | ﹤0.01% |
10,000
-198,500
| -95% | -$1.58M |
|
6188
Neonode
NEON
$15.3M
| $53.4K | ﹤0.01% |
+30,683
| New | +$81.2K |
|
|
ABP
6189
DELISTED
Abpro Holdings
ABP
| $52.4K | ﹤0.01% |
+12,383
| New | +$71.7K |
|
6190
Caesarstone
CSTE
$80.2M
| $52K | ﹤0.01% |
27,978
+604
| +2% | +$849 |
|
|
ARTV
6191
Artiva Biotherapeutics
ARTV
$563M
| $51.7K | ﹤0.01% |
12,060
-37,717
| -76% | -$142K |
|
6192
NetSol Technologies
NTWK
$50.8M
| $50.9K | ﹤0.01% |
16,810
+2,909
| +21% | +$10.6K |
|
6193
TechPrecision Corp
TPCS
$46.9M
| $50.8K | ﹤0.01% |
10,512
-147
| -1% | -$695 |
|
|
LGO
6194
Largo
LGO
$71.1M
| $50K | ﹤0.01% |
53,341
-27,868
| -34% | -$33.1K |
|
|
SBC
6195
SBC Medical Group
SBC
$313M
| $48.8K | ﹤0.01% |
+11,323
| New | +$43.2K |
|
6196
Tenaya Therapeutics
TNYA
$170M
| $48.4K | ﹤0.01% |
67,977
-159,520
| -70% | -$217K |
|
6197
Inovio Pharmaceuticals
INO
$70M
| $47.5K | ﹤0.01% |
27,288
-26,423
| -49% | -$58.2K |
|
|
GME.WS
6198
PUT
GameStop Corp Warrants
GME.WS
| $47.4K | ﹤0.01% |
+15,750
| New | +$48.9K |
|
6199
IRIDEX
IRIX
$14.7M
| $47.2K | ﹤0.01% |
41,385
-6,408
| -13% | -$6.6K |
|
6200
Arbe Robotics
ARBE
$86.6M
| $46.4K | ﹤0.01% |
+39,329
| New | +$65K |
|
Similar funds
Goldman Sachs's Q4 2025 Portfolio in Review
As of Q4 2025, Goldman Sachs held 6,954 positions worth $815B, down 0.25% from $817B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q4 2025 filing shows 640 new, 3,023 increased, 2,153 reduced and 543 closed positions. Its largest new stake was SunocoCorp LLC: 2,575,806 shares worth $127M. The largest sale was TC Energy, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q4 2025 buy was SunocoCorp LLC: 2,575,806 shares worth $127M.
- Goldman Sachs added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2025, an estimated $1.59B increase.
- Goldman Sachs's biggest Q4 2025 reduction was TC Energy, cutting an estimated $2.77B.
- Goldman Sachs fully exited Verona Pharma in Q4 2025, selling an estimated $207M.
- Goldman Sachs's ten largest holdings make up 22% of its $815B portfolio in Q4 2025.
- Goldman Sachs opened 640 new positions and closed 543 in Q4 2025.
- Goldman Sachs's portfolio value fell 0.25% quarter-over-quarter to $815B.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.